Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors

NCT01202032 is registered in ClinicalTrials.gov with Centre Leon Berard as lead sponsor.

NCT NCT01202032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01202032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bevacizumab in Patients With Metastatic Renal Cell Carcinoma or Others Advanced Solid Tumors
Lead sponsor
Centre Leon Berard
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2010
Completion date
March 31, 2013
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced refractory solid tumors histologically or cytologically confirmed, metastatic renal cell carcinoma